Nutriband (NASDAQ:NTRBW – Get Free Report) will likely be releasing its results before the market opens on Wednesday, September 30th. Analysts expect the company to post earnings of ($1.89) per share and revenue of $0.7650 million for the quarter.
Nutriband Price Performance
Shares of Nutriband stock opened at $1.66 on Tuesday. Nutriband has a fifty-two week low of $0.17 and a fifty-two week high of $2.99. The business’s fifty day moving average is $0.62 and its two-hundred day moving average is $0.96.
About Nutriband
Nutriband Inc is a medical technology company focused on the development, manufacturing and commercialization of transdermal and topical delivery systems. Its products are designed to deliver active pharmaceutical ingredients, nutraceuticals and other compounds through the skin using adhesive patches.
The company’s product portfolio includes consumer wellness patches and pharmaceutical delivery technologies. Nutriband has also developed Aversa, an abuse-deterrent transdermal system intended to help reduce the risk of drug extraction and misuse from certain prescription patches, including fentanyl patches.
Featured Articles
- Five stocks we like better than Nutriband
- Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?
- Brewing Trouble? Starbucks Spills the Beans on 250 Store Closures
- Stitch Fix Stock Plunges as Guidance Puts the Turnaround on Pause
- Harley-Davidson Insiders Are Buying: Is HOG Finally Turning Around?
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
